<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hemp Trading Post | gudrunseton69 | Activity</title>
	<link>https://www.hemptradingpost.com/members/gudrunseton69/activity/</link>
	<atom:link href="https://www.hemptradingpost.com/members/gudrunseton69/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for gudrunseton69.</description>
	<lastBuildDate>Tue, 14 Apr 2026 20:42:11 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">b72be2fa2783b10c1e56e522d813fbfa</guid>
				<title>gudrunseton69 started the topic Reuters Health News Summary in the forum Growing Hemp</title>
				<link>https://www.hemptradingpost.com/forums/topic/reuters-health-news-summary/</link>
				<pubDate>Mon, 28 Jun 2021 10:59:40 -0700</pubDate>

									<content:encoded><![CDATA[<p>&lt;p&gt;Following is a summary of current health news briefs.&lt;/p&gt; &lt;p&gt;Regeneron resumes enrollment in lymphoma drug trials&lt;/p&gt; &lt;p&gt;Regeneron Pharmaceuticals said on Monday it was resuming the enrollment of patients in two studies testing its experimental lymphoma drug after the U.S.<br />
Food and Drug Administration agreed to lift its partial clinical hold.&hellip;<span class="activity-read-more" id="activity-read-more-20021"><a href="https://www.hemptradingpost.com/forums/topic/reuters-health-news-summary/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>